Welcome to the Surg Onc Files! We are Washington University general surgery residents with an interest in surgical oncology. This is us trying to digest the latest research and trends in surg onc and often enlisting a lot of help to get us all the way there. Our goal is to cover surgical oncology from head to toe, discuss interesting topics in surgical oncology, and for each topic including where we are now, how got here, and what the future holds.
Soft Tissue Sarcoma 101
Welcome back to the SO Files! Shout out to our listeners for suggesting we dive into the world of soft tissue sarcomas. Soft Tissue Sarcomas are a very diverse group of cancers so today we focus on the two most common groupings - extremity vs retroperitoneal. We also bring Dr. Brian Van Tine on to focus on current trends in the field. Dr. Van Tine is an Associate Professor in the Division of Medical Oncology at Washington University who specializes in the treatment of soft tissue and bone sarcomas.
We also plug our Surg Onc Files Questionnaire which we designed to get to know you all a little better. It takes less than a minute to fill out so be sure to click the link and give us some feedback! https://www.surveymonkey.com/r/FMBC3F9
-Introduction and Sarcoma Overview: 0-25:50
-Interview with Dr. Van Tine: 25:50-
SurgOnc ABSITE Review: Part 2- GI, HPB, GU and Melanoma
Welcome back to the SO Files! Here you'll find the part two of our ABSITE-themed surgical oncology tour de force. On this 2nd part of our review we cover GI, HPB and GU cancers, as well as Melanoma. Our goal is to hit the high points on the major cancer topics throughout the body with the hopes of getting you an extra few points this weekend. Best wishes from the SurgOnc Files, good luck and happy studying!
SurgOnc ABSITE Review: Part 1- Head, Neck and Chest
Welcome back to the SO Files! With the ABSITE right around the corner we thought we'd go for a marathon session and build up our stamina for test day - here we present a head to toe review of all things surgical oncology that you might be asked this weekend. Although initially intended to be released en bloc, I think you'll understand why we broke this bad boy up. This part 1 of 2 podcast covers cancers from the head to diaphragm. So sit back and enjoy a brief review (~ 30 minutes) of high yield surgical oncology - and be sure to come back for part 2!
Melanoma Lymph Nodes with Dr. Mark Faries
On today's show we focus on melanoma and welcome Dr. Mark Faries onto the podcast. We discuss his role in the MSLT-I and MSLT-II trials as well as how their results have influenced the most recent editions of the NCCN and AJCC clinical practice guidelines. Before jumping into our interview with Dr. Faries, we take some time to introduce the basic staging principles for melanoma and the highlights of the MSLT-I and MSLT-II trials.
0-12:00 - Brad and Alston give overview of melanoma workup and 8th edition AJCC staging. Brief intro to MSLTI and MSLTII.
12:00- Interview with Dr. Faries
Gastric Cancer Deep Dive
Welcome back to the SO Files! We're happy to present part 2 of our gastric cancer series. Here we briefly review the historical gastric cancer classifications (Lauren and WHO) and then explain how this has drastically changed over the past 5-10 years with the advent of next-generation sequencing capabilities. We go in depth to evaluate how this applies to the budding surgical oncologist, and what discoveries may lie on the horizon. We also welcome back Dr. Ryan Fields, MD, FACS who is an Associate Professor in the Department of Surgery at Washington University in St. Louis and was recently appointed co-leader of the Solid Tumor Therapeutics Program (STTP) at Siteman Cancer Center. Dr. Fields talks about the outcomes of several recent trials and how they are helping us to treat gastric cancer patients in the clinic today. As always, all references from the podcast are linked below, enjoy!
Oncotype DX Score, TailorX Trial, and the Role of Oncotype DX Score in Breast Cancer Management
On this episode of SO Files, Alston, Brad and Linda take a closer look at the recently published TAILORx Clinical Trial Published in NEJM by Sparano and colleagues. The study expands the existing clinical application of the Oncotype DX score. If that score sounds familiar its because it has been making its way into clinical practice over the past few years (see our last episode on the new AJCC guidelines!). We explain the origin of the score, how it has been incorporated into clinical practice thus far, and how this trial addresses a large gap in the existing literature.